Interferon-Free Hepatitis C Therapy: How Close Are We?

By Pockros Paul J.  

Drugs, Vol. 72, Iss. 14, 2012-10 ,pp. : 1825-1831

Adis International

Access to resources Recommend Favorite

Incidence of Side Effects During Therapy with Different Types of Alpha Interferon: A Randomised Controlled Trial Comparing Recombinant Alpha 2b Versus Leukocyte Interferon in the Therapy of Naive Patients with Chronic Hepatitis C

By  

Current Pharmaceutical Design, Vol. 8, Iss. 11, 2002-05 ,pp. : 977-980

Bentham Science Publishers

Access to resources Recommend Favorite

Which is the Most Cost-Effective Combination Therapy Strategy Using Interferon -2b plus Ribavirin for Naïve Patients with Chronic Hepatitis C?

By Buti M.  

Clinical Drug Investigation, Vol. 22, Iss. 1, 2002-01 ,pp. : 31-39

Adis International

Access to resources Recommend Favorite

Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virus

By Foster Graham R  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 685-691

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in Pegylated Interferon Antiviral Therapy of Chronic Hepatitis C

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 5, Iss. 4, 2006-10 ,pp. : 379-387

Bentham Science Publishers

Access to resources Recommend Favorite